(1)
Pimentel, F. F.; Tiezzi, D. G.; Andrade, J. M. de; Gonçalves, J.; Cardoso, A. C. F.; Castilho, V. C.; Chammas, R.; Toledo, J. S. de. SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES. MAST 2021, 31, 9.